Search results :

Atazanavir

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AE08

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Cough 21% x x x x x x x
Amylase increased 19% x
Body temperature increased postmarketing — 18% - 19% x x x x x x x x x x x x x x x x
Rash postmarketing — 9% - 14% x x x x x x x x x x x x x x x x x
Scleral icterus postmarketing, 7% - 15% x x x x x x x x x x x x x x x
Neutropenia 9% - 12% x x x x
Diarrhoea postmarketing — 1% - 11% x x x x x x x x x x x x x x x x x
Vomiting common, 3% - 12% x x x x x x x x x x x x x x x x x
Headache common, 1% - 11% x x x x x x x x x x x x x x x x x
Jaundice postmarketing — 7% - 13% x x x x x x x x x x x x x x x x x
Oedema peripheral 7% x x x x x
Nasal congestion 6% x x x x
Pain in extremity 6% x x x x x
Wheezing 6% x x x x
Rhinorrhoea 6% x x x x x x x
Oropharyngeal pain 6% x x x x
Abdominal pain common, 4% - 11% x x x x x x x x x x x x x x x x x
Fatigue common x x x
Lipodystrophy common x x x
Ocular icterus common x
Hypoglycaemia 4% x x x x
Lipase increased 3% - 5% x x
Nausea postmarketing — 2% - 24% x x x x x x x x x x x x x x x x x
Haemoglobin decreased 3% x
Insomnia uncommon, 1% - 5% x x x x x x x x x x x x x x x x x
Dizziness uncommon, 1% - 8% x x x x x x x x x x x x x x x x x
Depression postmarketing, 1% - 5% x x x x x x x x x x x x x x x
Abdominal distension uncommon x x
Amnesia uncommon x x x
Anorexia uncommon x x x
Anxiety uncommon x x x
Asthenia uncommon x x x
Chest pain uncommon x x x
Drug eruption uncommon x
Dysgeusia uncommon x x x
Dyspnoea uncommon x x x
Eosinophilia uncommon x
Flatulence uncommon x x x
Gastritis uncommon x x x
Gynaecomastia uncommon x x x
Haematuria uncommon x x x
Hepatitis uncommon x x x
Hypersensitivity uncommon x x x
Hypertension uncommon x x x
Muscle atrophy uncommon x x x
Neuropathy peripheral uncommon x
Proteinuria uncommon x x x
Aphthous stomatitis uncommon x x x
Syncope uncommon x x x
Pollakiuria uncommon x x x
Urticaria uncommon x x x
Weight increased uncommon x x x
Weight decreased uncommon x x x
Dry mouth uncommon x x
Malaise uncommon x x x
Increased appetite uncommon x x x
Disorientation uncommon x
Sleep disorder uncommon x x x
Somnolence uncommon x x x
Alopecia postmarketing, uncommon x x x x x x x x x x x x x x
Angioedema postmarketing x x x
Arthralgia postmarketing, uncommon x x x x x x x x x x x x x x
Cholecystitis postmarketing x x x x x x x x x
Cholelithiasis postmarketing x x x x x x x x x
Cholestasis postmarketing x x x x x x x x x
Diabetes mellitus postmarketing, uncommon x x x x x x x x x x x x x x
Eczema rare x x x
Oedema postmarketing, rare x x x x x x x x x x x x x x
Fasting postmarketing x x x x x x x x x x x
Cardiac disorder postmarketing x x
Hepatosplenomegaly rare x x x
Hyperglycaemia postmarketing, uncommon x x x x x x x x x x x x x
Bundle branch block left postmarketing x x x x x x x x x
Myopathy rare x x x
Nephritis interstitial postmarketing x x x
Palpitations rare x x x
Pancreatitis postmarketing, uncommon x x x x x x x x x x x x x x
Pruritus postmarketing, uncommon x x x x x x x x x x x x x x
Torsade de pointes postmarketing, uncommon x x
Urinary tract disorder rare x
Angiopathy postmarketing x x
Atrioventricular block complete postmarketing x x x x x x x x x
Vesiculobullous rash rare x x x
Malnutrition postmarketing x x x x x x x x x x x x x x
Myalgia postmarketing, uncommon x x x x x x x x x x x x x x x x
Dyslipidaemia postmarketing x x x x x x x x x x x x x x x
Atrioventricular block second degree postmarketing x x x x x x x x x x x x
Hepatobiliary disease postmarketing x x x x x x x x x x
Nephrolithiasis postmarketing x x x x x x x x x x
Rash maculo-papular postmarketing x x x x x x x x x x x x
Renal pain rare x x x
Gait disturbance rare x x x
Electrocardiogram QT corrected interval prolonged postmarketing x x x x x x x x x
Lactic acidosis x
Amenorrhoea x
Atrioventricular block x
Autoimmune disorder x
Back pain x
Mental disorder x
Breast disorder x
Cellulitis x
Colitis x
Infection x
Confusional state x x
Connective tissue disorder x
Constipation x
Libido decreased x
Dehydration x
Dermatophytosis x
Dyspepsia x x x
Ecchymosis x
Erythema multiforme x
Oesophagitis x
Eye disorder x
Gastroenteritis x
Gastrointestinal disorder x x
Gout x
Basedow's disease x
Hallucination x
Cardiac arrest x
Block heart x
Hepatitis C x x x x x x x x x x x x x x x
Hepatomegaly x
Hiccups x
Hostility x
Hyperbilirubinaemia x x x x x x
Hypercholesterolaemia x
Hypertriglyceridaemia x
Hypertrophy of breast x
Hypoaesthesia x
Immune system disorder x
Inflammation x
Insulin resistance x
Calculus of kidney x
Mediastinal disorder x
Menstrual disorder x
Myocarditis x
Nail disorder x
Nervous system disorder x
Nervousness x
Obesity x
Oliguria x
Opportunistic infection x
Otitis x
Pain x x
Pallor x
Pelvic pain x
Peptic ulcer x
Polyuria x
Psychotic disorder x
Purpura x
Renal failure x
Seborrhoeic dermatitis x
Convulsion x
Staphylococcal scalded skin syndrome x
Stevens-Johnson syndrome x
Suicide attempt x
Sweating x
Tinnitus x
Toothache x
Urinary tract infection x
Hepatitis viral x
Burning sensation x
Agitation x
Mood swings x
Mouth ulceration x
Crystalluria x
Generalised oedema x
Fertility male decreased x
Hepatocellular injury x
Liver fatty deposition x
Bone pain x
Retrosternal pain x
Hyperreflexia x
Aspartate aminotransferase increased x
Alanine aminotransferase increased x x
Dry skin x
Oesophageal ulcer x
Unspecified disorder of skin and subcutaneous tissue x
Heat intolerance x
Muscle twitching x
Neurological symptom x x x x x x x x x x x x x
Urine abnormality x
Erectile dysfunction x
Eruption x
Blood bilirubin increased x
Atrophy x
Dysplasia x
Photosensitivity x
Enlargement abdomen x
Hyperkinesia x
Buffalo hump x x
Chronic hepatitis B x
Cough increased x
Drug interaction x
Bilirubin total increased x
Hyperlactacidaemia x
Myasthenia x
Acholia x
Lipohypertrophy x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ATAZANAVIR SULFATE / REYATAZ

Side effects:11
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:17
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:17
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:27
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:27
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:28
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:34
Source:FDA

atazanavir sulfate / Reyataz

Side effects:35
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:38
Source:FDA

ATAZANAVIR SULFATE / REYATAZ

Side effects:38
Source:FDA

ATAZANAVIR

Side effects:44
Source:FDA Structured Product Label

ATAZANAVIR

Side effects:44
Source:FDA Structured Product Label

ATAZANAVIR

Side effects:47
Source:FDA Structured Product Label

ATAZANAVIR

Side effects:50
Source:FDA Structured Product Label

ATAZANAVIR (ATAZANAVIR SULFATE) / REYATAZ

Side effects:81
Source:Health Canada

atazanavir / REYATAZ

Side effects:135
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label